
CNTB Valuation
Connect Biopharma Holdings Ltd
- Overview
- Forecast
- Valuation
- Earnings
CNTB Relative Valuation
CNTB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CNTB is overvalued; if below, it's undervalued.
Historical Valuation
Connect Biopharma Holdings Ltd (CNTB) is now in the Fair zone, suggesting that its current forward PS ratio of 51.56 is considered Fairly compared with the five-year average of -3.65. The fair price of Connect Biopharma Holdings Ltd (CNTB) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:2.22
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
1.57
P/B
Median3y
0.53
Median5y
0.94
-26.81
FCF Yield
Median3y
-108.06
Median5y
-90.40
Competitors Valuation Multiple
The average P/S ratio for CNTB's competitors is 9.57, providing a benchmark for relative valuation. Connect Biopharma Holdings Ltd Corp (CNTB) exhibits a P/S ratio of 51.56, which is 438.73% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
People Also Watch

NVNO
enVVeno Medical Corp
4.960
USD
-1.20%

MPU
Mega Matrix Inc
2.680
USD
+7.63%

PODC
Podcastone Inc
1.895
USD
-1.30%

FGEN
FibroGen Inc
7.450
USD
+3.04%

GODN
Golden Star Acquisition Corp
2.910
USD
0.00%

BCOW
1895 Bancorp of Wisconsin Inc
0
USD
-7.45%

PRLD
Prelude Therapeutics Inc
0.930
USD
+1.97%

BGSF
BGSF Inc
6.440
USD
+1.74%

BAFN
Bayfirst Financial Corp
14.496
USD
-3.04%

BEAT
Heartbeam Inc
1.270
USD
-0.78%
FAQ

Is Connect Biopharma Holdings Ltd (CNTB) currently overvalued or undervalued?
Connect Biopharma Holdings Ltd (CNTB) is now in the Fair zone, suggesting that its current forward PS ratio of 51.56 is considered Fairly compared with the five-year average of -3.65. The fair price of Connect Biopharma Holdings Ltd (CNTB) is between to according to relative valuation methord.

What is Connect Biopharma Holdings Ltd (CNTB) fair value?

How does CNTB's valuation metrics compare to the industry average?

What is the current P/B ratio for Connect Biopharma Holdings Ltd (CNTB) as of Jul 26 2025?

What is the current FCF Yield for Connect Biopharma Holdings Ltd (CNTB) as of Jul 26 2025?

What is the current Forward P/E ratio for Connect Biopharma Holdings Ltd (CNTB) as of Jul 26 2025?
